M&A Deal Summary

Intersect ENT Acquires Fiagon AG

On September 15, 2020, Intersect ENT acquired medical products company Fiagon AG for 60M USD

Acquisition Highlights
  • This is Intersect ENT’s 1st transaction in the Medical Products sector.
  • This is Intersect ENT’s largest (disclosed) transaction.
  • This is Intersect ENT’s 1st transaction in Germany.

M&A Deal Summary

Date 2020-09-15
Target Fiagon AG
Sector Medical Products
Buyer(s) Intersect ENT
Deal Type Add-on Acquisition
Deal Value 60M USD
Advisor(s) Oppenheimer & Co. (Financial)
Morrison & Foerster (Legal)

Target

Fiagon AG

Stadt Hennigsdorf, Germany
Fiagon develops and manufactures state-of-the-art surgical navigation equipment with its proprietary tip-tracked technology. Over the past ten years Fiagon, along with world-renowned physicians, changed the standard of ENT navigation with its easy-to-use electromagnetic based technology. This unique technology is also currently used in oral and maxillofacial surgery, neurosurgery, and spine surgery, outside the US, mainly in Europe and Asia. Fiagon was formed in 2007 and is based in Stadt Hennigsdorf, Germany.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Intersect ENT

Menlo Park, California, United States

Category Company
Founded 2003
Sector Medical Products
Employees406
Revenue 81M USD (2020)
DESCRIPTION

Intersect ENT is a medical technology company dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients. Intersect ENT was founded in 2003 and is headquartered in Menlo Park, California.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1